Freedom Capital initiated coverage of Globus Medical (GMED) with a Hold rating and $87 price target The firm says the company’s “solid” organic growth is already reflected in the shares.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMED: